Skip to content

Solventum SOLV Revenue recognized that was included in deferred income at the beginning of the period

Revenue recognized that was included in deferred income at the beginning of the period at other companies

Baxter International logo
Baxter InternationalBAX
$46M+35.3%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's revenue recognized that was included in deferred income at the beginning of the period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's revenue recognized that was included in deferred income at the beginning of the period?
Solventum (SOLV) reported revenue recognized that was included in deferred income at the beginning of the period of $226M in Q1 2026.
How has Solventum's revenue recognized that was included in deferred income at the beginning of the period changed year-over-year?
Solventum's revenue recognized that was included in deferred income at the beginning of the period increased by 2.7% year-over-year, from $220M to $226M.